0001104659-22-003162.txt : 20220111
0001104659-22-003162.hdr.sgml : 20220111
20220111160840
ACCESSION NUMBER: 0001104659-22-003162
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220107
FILED AS OF DATE: 20220111
DATE AS OF CHANGE: 20220111
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ravina Bernard
CENTRAL INDEX KEY: 0001711276
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39620
FILM NUMBER: 22523981
MAIL ADDRESS:
STREET 1: C/O VOYAGER THERAPEUTICS, INC.
STREET 2: 75 SIDNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Praxis Precision Medicines, Inc.
CENTRAL INDEX KEY: 0001689548
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 99 HIGH STREET, 30TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02110
BUSINESS PHONE: 617-300-8460
MAIL ADDRESS:
STREET 1: 99 HIGH STREET, 30TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02110
4
1
tm222494-4_4seq1.xml
OWNERSHIP DOCUMENT
X0306
4
2022-01-07
0
0001689548
Praxis Precision Medicines, Inc.
PRAX
0001711276
Ravina Bernard
C/O PRAXIS PRECISION MEDICINES, INC.
99 HIGH STREET, 30TH FLOOR
BOSTON
MA
02110
0
1
0
0
Chief Medical Officer
Common Stock
2022-01-07
4
A
0
22000
0
A
102533
D
Stock Option (Right to Buy)
18.11
2022-01-07
4
A
0
77000
0
A
2032-01-07
Common Stock
77000
77000
D
Dr. Ravina was awarded 22,000 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. The restricted stock units vest in equal annual installments over a four-year period beginning on January 7, 2023, subject to the reporting person's continued service through each vesting date. The restricted stock units may be settled only by delivering shares of the Issuer's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance.
The shares underlying this stock option vest over a four-year period, with 25% vesting on January 7, 2023 and the remaining 75% vesting in 36 equal monthly installments thereafter, subject to the reporting person's continued service through each vesting date.
/s/ Alex Nemiroff, as Attorney-in-Fact
2022-01-11